GRk1 was also reported to have anti-tumor activity against lung squamous cell carcinoma [102], and at 30 mg/kg, GRk1 injections markedly inhibited tumor xenograft growth [103]. This evidence concerns the gene GRK1 and squamous cell lung carcinoma.